Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

KarinCA,

¨Edit to add... as another poster has pointed out, this article is dealing with radioprotection, not drugs such as Brilacidin. It's not surprise to not see Brilacidin mentioned.¨

Agree, but regardless of the mechanism of action(design), I trust that all those involved with OM research, including ipix, seek a better treatment than what is presently approved and available.

Thanks Empiricist1 for posting that link. I find it informative to compare and assess. Although I may become a bit more disgruntled with each passing day, I do realize patience is a virtue, and trust that the following statement from Dr. Bertolino in the ipix 4/9/18 pr rings true: “Reducing incidence of SOM sets the gold standard and is key to capturing the large HNC market currently lacking any approved drugs. With this new expanded information on the effectiveness of Brilacidin-OM, coupled with our previously reported successful primary results, we think our novel compound continues to raise the bar as the leading SOM drug in development.”, not to mention similiar quotes pertaining to Prurisol for psoriasis.

Competition is good

GLTA,

KFC

p.s- never heard of this company til empicicst1 post. Competition is always good, clearly ipix has more than one competitor in the OM market.

1. EpicentRX team: http://www.epicentrx.com/team-mission/

2. EpicentRX 8/9/18 Science Trends article(including poem, a must read). https://sciencetrends.com/radioprotectors-defensive-weapons-in-the-war-on-cancer/